Cephalalgia

Article	Citations
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	120
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	102
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome	94
Harassment in the headache field: a global web-based cross-sectional survey	72
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	72
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	63
International Classification of Headache Disorders-4 – Work in Progress 1	49
Efficacy of different cannabinoid compounds on migraine-like responses in female rats	46
Evidence-based guidelines for the pharmacological treatment of migraine	40
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review	38
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	38
Systemic lupus erythematosus mimicking retinal migraine: a case report	37
An altered reward system characterizes chronic migraine with medication overuse headache	37
Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches	36
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	35
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	35
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	33
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	33
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	33
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	32
Depression screening in migraine - A double-edged sword	32
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	32
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	31
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	30

Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	30
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review	29
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	29
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	29
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	28
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	28
Looking at Cephalalgia from the inside	27
Comorbidity or combination – more evidence for cluster-migraine?	27
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	27
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’	27
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	26
Sex differences in photophobic behaviors following cortical spreading depression in rats	25
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	25
What is the evolutionary disadvantage of migraine?	25
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	23
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	22
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	22
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	21
Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study	20
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	20
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	20
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	20
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update	20
Neck pain in migraine: A narrative review and steps to correct evaluation and treatment	19
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	19
Genome sequencing reveals the Adgrl3 ( ADGRL3 ) gene as a possible cause of cephalic hypersensitivity in the STA rat and migraine in human	19
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	19
The midfacial segment pain: little known disorder in need of scientific evaluation	19
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex	18
Thanks to Reviewers	18
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adu	18
Abstracts from the International Headache Congress 14–17 September 2023	18
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	18
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies	18
Burden of headache in a HIV-positive population of sub-Saharan Africa	18
Psychophysical testing in chronic migraine and chronic tension type headache: An observational study	18
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society	17
Muscae volitantes: A 19th-century precursor of visual snow syndrome?	17
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study	17
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	17
The “index vein” as a sign for migraine aura in the emergency setting	17
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	17
Plasma adrenomedullin levels in migraine: A registry for migraine (REFORM) study	17
Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population	16
Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study	16
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	16
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”	16
Internet and social media's role in migraine education: Headache or not headache?	16
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	16
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he	16

Erratum	16
The impact of eating disorders on idiopathic intracranial hypertension	15
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients	15
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine	15
Shared genetics and causal relationships between migraine and thyroid function traits	15
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society	15
Brain imaging in migraine with and without aura: Similarities and differences	15
The effect of treatment onset time on acute efficacy in migraine patients treating with remote electrical neuromodulation (REN)	15
Are we closer to achieving precision medicine for migraine treatment? A narrative review	15
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study	15
Comorbidity with fibromyalgia predicted poorer outcomes in patients with chronic migraine on flunarizine: Prospective proof-of-concept study	15
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days	15
Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	14
Board Walk – April 2022	14
Avoidance behaviour modulates but does not condition phonophobia in migraine	14
Premonitory symptoms in migraine: A REFORM Study	14
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	14
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication	14
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”	14
Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension	14
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study	13
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	13
Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America	13
Hypnic Headache – What do we know in 2022?	13
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature	13
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury	13
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study	13
Headache at the chronic stage of cerebral venous thrombosis	13
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review	13
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study	13
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials	13
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”	13
Prevalence of neck pain in migraine: A systematic review and meta-analysis	13
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial	12
Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache	12
Generative chatbots in headache education and research: A narrative review	12
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	12
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments	12
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura	12
Late Breaking Author Index	12
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	12
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review	12
Proposed general diagnostic criteria for secondary headaches	12
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	12
Cephalalgia: a legacy of excellence, a vision for tomorrow	12
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	12
Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care. A position paper of the IHS Child and Adolescent Committee	11
Research to improve headache classification: Results, methods, and future challenges	11
Other primary headaches: Distinct clinical features and uncertain pathophysiology	11
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	11
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	11
It's not either-or: Why migraine care needs both real-world evidence studies and randomized controlled trials	11
Adjunctive occipital nerve block for emergency treatment of acute migraine: A randomized, controlled trial	11
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models	11
Multidisciplinary headache treatment with work-focus in Norway: An observational study	11
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	11
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial	11
The psychometric properties of an e-headache diary in migraine	11
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	10
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	10
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	10
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center	10
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	10
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients	10
Epicranial headaches part 2: Nummular headache and epicrania fugax	10
Personal view: Modelling pain mechanisms of migraine without aura	10
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study	10
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	10
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	10
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	10
Headache provocation by nitric oxide in men who have never experienced a headache	10
NCOR2 is a novel candidate gene for migraine-epilepsy phenotype	9
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine	9
It is a long way to the top if you wanna citations?	9
Lack of a direct link between macular cones function and photophobia in interictal migraine	9
Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	9
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	9
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	9
A narrative review of app- and internet-delivered headache interventions: From ideation to implementation and the future	9
FollowTheSutures: Piloting a new way to administer onabotulinumtoxinA for chronic migraine	9

Investigations of the migraine-provoking effect of levcromakalim in patients with migraine with aura	9
Investigations of the subarachnoid space as a potential link between aura and headache in migraine: A case-control MRI study	9
The evolutionary meaning of migraine	9
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	9
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	9
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	9
Substance P and the trigeminovascular system: From preclinical mechanisms to human headache induction	9
A systematic evaluation of primary headache management apps leveraging behavior change techniques	9
Reviewing the complex relationship between circadian rhythms and cluster headache	9
Visual snow syndrome is probably not mediated by CGRP: A case series	9
Transition of cluster headache phenotype: An interview-based study	9
Update on cough, exertional and sex headache	9
ANODYNE study: A double-blind randomized trial of greater occipital nerve block of methylprednisolone and lignocaine versus placebo as a transitional preventive treatment for episodic cluster headache	9
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	9
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	9
Reaching international consensus on the definition of refractory migraine using the Delphi method	9
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	9
Update in the understanding of new daily persistent headache	9
Effectiveness of physiotherapy interventions on headache intensity, frequency, duration and quality of life of patients with tension-type headache. A systematic review and network meta-analysis	9
Functional magnetic resonance imaging in migraine: A systematic review	8
Studying migraine as a risk factor for stroke: The importance of working with an explicit causal framework	8
Prolonged headache with vaccine- and dose-specific headache pattern associated with vaccine against SARS-CoV-2 in patients with migraine	8
A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache	8
The prevalence of headache disorders in Postural Tachycardia Syndrome: A systematic review and meta-analysis of the literature	8
Comment on: Setting higher standards for migraine prevention: A position statement of the International Headache Society	8
Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache	8
The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses	8
Identification of patients with chronic migraine by using sensory-evoked oscillations from the electroencephalogram classifier	8
Pharmacologic characterization of atogepant: A potent and selective calcitonin gene–related peptide receptor antagonist	8
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two	8
Cranial autonomic symptoms as a protective mechanism in patients with chronic migraine: A cross-sectional study	8
Corrigendum to: “CLOCK gene circannual expression in cluster headache”	8
Effect of KATP channel blocker glibenclamide on PACAP38-induced headache and hemodynamic	8
Characteristics of pre-cluster symptoms in cluster headache: A cross-sectional multicentre study	8
Diagnosis of idiopathic intracranial hypertension: A proposal for evidence-based diagnostic criteria	8
Functional brainstem representations of the human trigeminal cervical complex	7
Raising the bar in migraine prevention: Toward freedom and optimal control	7
Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees	7
Continuous positive airway pressure in cluster headache: A randomized, placebo-controlled, triple-blind, crossover study	7
Thanks to Reviewers	7
Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache	7
Clinical analysis of 30 cases of cardiac cephalalgia	7
Complementary, but not equivalent: Clarifying the role of RWE and RCT in migraine research	7
Medication “underuse” headache	7
A comparative study on prophylactic efficacy of cinnarizine and amitriptyline in childhood migraine: a randomized double-blind clinical trial	7
Methodology of drug trials in migraine: History and suggestions for the future	7
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine	7
Author Index	7
Prevalence, clinical characteristics and associated factors of cardiac cephalalgia: A prospective study	7
Sensitizing effect of antimigraine drug sumatriptan on capsaicin-sensitive lung vagal neurons via 5-HT 1B/1D receptors and PKA: Relevance to adverse chest effects	7
Epidemiology and clinical features of short-lasting unilateral neuralgiform headache attacks: A systematic review and meta-analysis	7
Enhanced audiovisual associative pair learning in migraine without aura in adult patients: An unexpected finding	7
Minimal important difference of the Migraine Disability Assessment (MIDAS): Longitudinal data from the DMKG Headache Registry	7
Effects of substance P on headache induction and arterial dilation in healthy adults	7
Calcitonin receptor antibody validation and expression in the rodent brain	7
What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies	7
Nerve matters: Longitudinal microstructural change in the trigeminal nerve is associated with durable pain relief after surgery for trigeminal neuralgia	6
Differences in cortical morphometry between persistent post-traumatic headache, migraine and healthy controls	6
DNA-methylation and immunological response in medication overuse headache	6
Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication overuse headache registry	6
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache	6
Building community and visibility: A year of social media growth for Cephalalgia	6
CLOCK gene circannual expression in cluster headache	6
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis	6
PACAP versus CGRP in migraine: From mouse models to clinical translation	6
Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data	6
Pediatric screen exposure and school related headache disability	6
Longitudinal analysis of pain-induced brain activations in post-traumatic headache	6
Migraine stigma and general knowledge of migraine: A cross-sectional European survey	6
Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?	6
An analysis of diffusion tensor imaging in classical trigeminal neuralgia	6
Impact and care gaps of headache disorders in active-duty military personnel: A cross-sectional study from a European armed forces population	6
PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation	6
Inhibiting PAC1 receptor internalization and endosomal ERK pathway activation may ameliorate hyperalgesia in a chronic migraine rat model	6
The epidemiology of airplane headache: A cross-sectional study on point prevalence and characteristics in 50,000 travelers	6
Neuromodulation in trigeminal autonomic cephalalgias: 11-year experience of non-invasive vagus nerve stimulation	6
A response: Update on cough, exertional and sex headache	6
COVID-19 vaccination elicited de novo and recurrence of cluster headache: A case series	5
Abstract Authors Index for MTIS 2022	5
New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy	5
The burden of headache disorders in Pakistan: National estimates from a population-based door-to-door survey and a healthcare needs assessment	5
Increased prevalence of migraine in women with inflammatory bowel disease: A cross-sectional study	5
Head/neck pain characteristics after spontaneous cervical artery dissection in the acute phase and on a long-run	5
Transorbital sonography: A non-invasive bedside screening tool for detection of pseudotumor cerebri syndrome	5
The short-term effects of CGRP monoclonal antibodies on bone turnover: A prospective cohort study	5
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action	5
Reply to Wasserman et al.: Elucidating the “Triggers” versus “Maintenance” in burning mouth syndrome/oral dysaesthetic and perceptual disorder	5
Chronic cluster headache is a rare disease: Implications for diagnosis, treatment and public health	5
Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up	5
Cervical musculoskeletal dysfunctions in pediatric migraine: A cross-sectional study	5
Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation	5
Abnormal electromyographical trigeminal activation through stimulation of the offending artery (Z-L response): An intraoperative tool during microvascular decompression for trigeminal neuralgia	5
Evaluation of the ICHD-3 diagnostic criteria for cardiac cephalalgia and new proposal	5
Perceived barriers to career progression in the headache field: A global web-based cross-sectional survey	5
Insufficient sleep may alter cortical excitability near the migraine attack: A blinded TMS crossover study	5